Last updated on August 2019

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND


Brief description of study

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.

Clinical Study Identifier: NCT03587805

Find a site near you

Start Over

LEO Pharma Investigational Site

Etobicoke, ON Canada
1.85miles
  Connect »

LEO Pharma Investigational Site

Mississauga, ON Canada
6.7miles
  Connect »

LEO Pharma Investigational Site

Toronto, ON Canada
7.36miles
  Connect »